Theragen Etex Co.,Ltd. (KOSDAQ:066700)

Theragen Etex Statistics

Total Valuation

Theragen Etex has a market cap or net worth of KRW 111.15 billion. The enterprise value is 140.31 billion.

Market Cap	111.15B
Enterprise Value	140.31B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Theragen Etex has 36.68 million shares outstanding. The number of shares has increased by 16.69% in one year.

Current Share Class	36.68M
Shares Outstanding	36.68M
Shares Change (YoY)	+16.69%
Shares Change (QoQ)	+2.92%
Owned by Insiders (%)	31.10%
Owned by Institutions (%)	0.97%
Float	22.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.43
PB Ratio	0.79
P/TBV Ratio	0.95
P/FCF Ratio	n/a
P/OCF Ratio	61.60
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.62, with an EV/FCF ratio of -21.51.

EV / Earnings	-3.10
EV / Sales	0.54
EV / EBITDA	5.62
EV / EBIT	7.47
EV / FCF	-21.51

Financial Position

The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.35.

Current Ratio	1.48
Quick Ratio	1.07
Debt / Equity	0.35
Debt / EBITDA	2.64
Debt / FCF	-7.67
Interest Coverage	4.75

Financial Efficiency

Return on equity (ROE) is -27.64% and return on invested capital (ROIC) is 3.94%.

Return on Equity (ROE)	-27.64%
Return on Assets (ROA)	3.06%
Return on Invested Capital (ROIC)	3.94%
Return on Capital Employed (ROCE)	8.65%
Revenue Per Employee	1.28B
Profits Per Employee	-223.75M
Employee Count	202
Asset Turnover	0.99
Inventory Turnover	3.95

Taxes

Income Tax	-4.21B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.40% in the last 52 weeks. The beta is 0.29, so Theragen Etex's price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	-21.40%
50-Day Moving Average	2,982.70
200-Day Moving Average	3,227.23
Relative Strength Index (RSI)	54.33
Average Volume (20 Days)	54,315

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Theragen Etex had revenue of KRW 258.02 billion and -45.20 billion in losses. Loss per share was -1,401.95.

Revenue	258.02B
Gross Profit	130.53B
Operating Income	12.79B
Pretax Income	-48.39B
Net Income	-45.20B
EBITDA	18.96B
EBIT	12.79B
Loss Per Share	-1,401.95

Balance Sheet

The company has 39.94 billion in cash and 50.02 billion in debt, giving a net cash position of -10.08 billion or -274.71 per share.

Cash & Cash Equivalents	39.94B
Total Debt	50.02B
Net Cash	-10.08B
Net Cash Per Share	-274.71
Equity (Book Value)	141.29B
Book Value Per Share	3,331.20
Working Capital	46.59B

Cash Flow

In the last 12 months, operating cash flow was 1.80 billion and capital expenditures -8.33 billion, giving a free cash flow of -6.52 billion.

Operating Cash Flow	1.80B
Capital Expenditures	-8.33B
Free Cash Flow	-6.52B
FCF Per Share	-177.79

Margins

Gross margin is 50.59%, with operating and profit margins of 4.96% and -17.52%.

Gross Margin	50.59%
Operating Margin	4.96%
Pretax Margin	-18.75%
Profit Margin	-17.52%
EBITDA Margin	7.35%
EBIT Margin	4.96%
FCF Margin	n/a

Dividends & Yields

Theragen Etex does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.69%
Shareholder Yield	n/a
Earnings Yield	-40.66%
FCF Yield	-5.87%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Theragen Etex has an Altman Z-Score of 2.04 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.04
Piotroski F-Score	6